Correlation Between GeneReach Biotechnology and Kinsus Interconnect

Can any of the company-specific risk be diversified away by investing in both GeneReach Biotechnology and Kinsus Interconnect at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GeneReach Biotechnology and Kinsus Interconnect into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between GeneReach Biotechnology and Kinsus Interconnect Technology, you can compare the effects of market volatilities on GeneReach Biotechnology and Kinsus Interconnect and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GeneReach Biotechnology with a short position of Kinsus Interconnect. Check out your portfolio center. Please also check ongoing floating volatility patterns of GeneReach Biotechnology and Kinsus Interconnect.

Diversification Opportunities for GeneReach Biotechnology and Kinsus Interconnect

0.4

Correlation Coefficient

GeneReach Biotechnology  Kinsus Interconnect

Very weak diversification

The 3 months correlation between GeneReach and Kinsus is 0.4. Overlapping area represents the amount of risk that can be diversified away by holding GeneReach Biotechnology and Kinsus Interconnect Technology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kinsus Interconnect and GeneReach Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GeneReach Biotechnology are associated (or correlated) with Kinsus Interconnect. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kinsus Interconnect has no effect on the direction of GeneReach Biotechnology i.e., GeneReach Biotechnology and Kinsus Interconnect go up and down completely randomly.

Pair Corralation between GeneReach Biotechnology and Kinsus Interconnect

Assuming the 90 days trading horizon GeneReach Biotechnology is expected to under-perform the Kinsus Interconnect. But the stock apears to be less risky and, when comparing its historical volatility, GeneReach Biotechnology is 1.86 times less risky than Kinsus Interconnect. The stock trades about -0.1 of its potential returns per unit of risk. The Kinsus Interconnect Technology is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  10,650  in Kinsus Interconnect Technology on October 9, 2024 and sell it today you would earn a total of  300.00  from holding Kinsus Interconnect Technology or generate 2.82% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

GeneReach Biotechnology  vs.  Kinsus Interconnect Technology

GeneReach Biotechnology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days GeneReach Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

Kinsus Interconnect

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Kinsus Interconnect Technology are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, Kinsus Interconnect is not utilizing all of its potentials. The current stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Pair Trading with GeneReach Biotechnology and Kinsus Interconnect

The main advantage of trading using opposite GeneReach Biotechnology and Kinsus Interconnect positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GeneReach Biotechnology position performs unexpectedly, Kinsus Interconnect can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kinsus Interconnect will offset losses from the drop in Kinsus Interconnect's long position.

The idea behind GeneReach Biotechnology and Kinsus Interconnect Technology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.